The Texas-based company’s products were among the 55,000 vape applications, or PMTAs, rejected by the FDA for insufficient documentation. The court of appeals rightly stated that the FDA pulled a “surprise switcheroo” from earlier guidance, when it failed to mention that applicants should provide long-term studies to support their applications. The court also pointed out […]

Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email